Louise presented her work, Expanding the toolkit for mouse genome editing: Analysis of CRISPR variants with different PAM recognition.
This is what Louise had to say about her experience in New York.
Did you meet any researchers or collaborators of significance? Why they are important to your work?
I met and shared research with Peter Romaneiko who runs the Genome Editing Core Facility at Rutgers Cancer Institute of New Jersey. He was very interested in the work we have been doing on variants of the CRISPR technology and was able to share some of his experiences with mouse genome editing. Additionally, I met Channabasavaiah Gurumurthy, who pioneered the easi-CRISPR method that we use in our laboratory.
What was a highlight of the conference?
Attending Jennifer Doudna’s talk. She is an important researcher in the field and has been working on an exciting new high-fidelity Cas9 variant.
How will the experience support you and your research going forward?
I was able to network with a lot of like-minded people working on incredibly diverse projects, many of whom will be great contacts in the future. Seeing the variety of projects and the different ways that people use CRISPR technology will be invaluable going forward when tackling new biological questions and projects.
What was the most exciting thing you experienced at the Conference?
It was very exciting to have Rudolf Jaenisch join our mouse users meeting and share his insights on CRISPR in mice and to be able to share my findings with him and the many experienced researchers in the room.